NOVEL IMMUNOTHERAPIES (CAR-T, BiTE)
The Cardiovascular Complications of Chimeric Antigen Receptor T-Cell Therapy
In the absence of formal guidelines for the mitigation and management of CAR T-cell therapy–associated cardiotoxicity, the authors discuss the direct and indirect mechanisms of toxicity and share their own strategic care approaches.
Current Hematologic Malignancy Reports
